Dare Bioscience: Q1 Earnings Insights

 

Dare Bioscience DARE reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

Dare Bioscience beat estimated earnings by 28.57%, reporting an EPS of $-0.1 versus an estimate of $-0.14.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 14.77% increase in the share price the next day.

 

To track all earnings releases for Dare Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

DARE Logo
DAREDare Bioscience Inc
$3.002.78%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
16.44
Growth
Not Available
Quality
Not Available
Value
1.24
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...